Clinical trial

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

NCT00825045

Study summary

ClinicalTrials.gov

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record risperidone Normalized identity: risperidone View linked drug · Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2008-12-01

PhaseNA

Conditions

Schizophreniaverified · MONDO: schizophrenia

Schizoaffective Disorderverified · MONDO: schizoaffective disorder

Schizophreniform Disorderverified · MONDO: schizophreniform disorder

Interventions

risperidoneDRUG · verified · RxNorm: risperidone

Sponsors & collaborators

Centre for Addiction and Mental Healthlead sponsor

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00825045 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.